Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bipolar Disorder With Psychotic Features”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Not applicableStudy completedNCT01075295
What this trial is testing

Prevention of Weight Gain in Early Psychoses

Who this might be right for
Schizophreniform DisorderBipolar I DisorderBipolar II Disorder+5 more
Centre for Addiction and Mental Health 70
Not applicableStudy completedNCT04874974
What this trial is testing

Feasibility of a Novel Process-based Treatment for Patients With Psychosis

Who this might be right for
SchizophreniaSchizotypal DisorderDelusional Disorder+10 more
Max-Planck-Institute of Psychiatry 37
Not applicableLooking for participantsNCT07713849
What this trial is testing

Transition Care for FEP

Who this might be right for
Schizoaffective DisordersBipolar Disorder With Psychotic FeaturesSchizophrenia Disorders+2 more
University of Chicago 75
Large-scale testing (Phase 3)Study completedNCT00421954
What this trial is testing

Open-label Ziprasidone Study for Psychosis Treatment in Adolescents

Who this might be right for
Schizophreniform DisorderSchizoaffective DisorderPsychosis+2 more
New York State Psychiatric Institute 8
Not applicableStudy completedNCT00531518
What this trial is testing

Early Detection and Intervention for the Prevention of Psychosis

Who this might be right for
SchizophreniaBipolar DisorderDepression+1 more
MaineHealth 292
Large-scale testing (Phase 3)Study completedNCT00102518
What this trial is testing

Aripiprazole Open-Label, Safety and Tolerability Study

Who this might be right for
SchizophreniaBipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 325
Not applicableStudy completedNCT00179062
What this trial is testing

Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder

Who this might be right for
SchizophreniaSchizoaffective DisorderDepressive Disorder, Major+1 more
Vanderbilt University 300
Not applicableStudy completedNCT01597141
What this trial is testing

Psychosis: Early Detection, Intervention and Prevention

Who this might be right for
Prodromal SchizophreniaPsychotic DisordersSevere Bipolar Disorder With Psychotic Features+1 more
MaineHealth 100
Large-scale testing (Phase 3)Ended earlyNCT01122927
What this trial is testing

Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.

Who this might be right for
Adolescent SchizophreniaChild or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Otsuka Pharmaceutical Development & Commercialization, Inc. 524
Testing effectiveness (Phase 2)Looking for participantsNCT07288320
What this trial is testing

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

Who this might be right for
Bipolar I DisorderMania
Neurocrine Biosciences 150